Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center

Disparities in gynecologic cancer genetics evaluation

(2019) Emily M. Hinchcliff et al.   GYNECOLOGIC ONCOLOGY

Disparities in genetics assessment for women with ovarian cancer: Can we do better?

(2018) Erica Manrriquez et al.   GYNECOLOGIC ONCOLOGY

ACOG Committee Opinion No. 727

(2018)   OBSTETRICS AND GYNECOLOGY

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper

(2017) Leslie M. Randall et al.   GYNECOLOGIC ONCOLOGY

Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer

(2017) Allison W. Kurian et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Genetic/Familial High-Risk Assessment: Breast and Ovarian

(2017) Mary B. Daly et al.   Journal of the National Comprehensive Cancer Network

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017

(2016) Mary B. Daly et al.   Journal of the National Comprehensive Cancer Network

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015

(2016) Mary B. Daly et al.   Journal of the National Comprehensive Cancer Network

The future of clinical cancer genomics

(2016) Kenneth Offit   SEMINARS IN ONCOLOGY

Inherited Mutations in Women With Ovarian Carcinoma

(2016) Barbara M. Norquist et al.   JAMA Oncology

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions

(2015) Johnathan M. Lancaster et al.   GYNECOLOGIC ONCOLOGY

Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2

(2015) Michael Dean et al.   GigaScience

Multigene Panel Testing in Oncology Practice

(2015) Allison W. Kurian et al.   JAMA Oncology

Utilization and Outcomes ofBRCAGenetic Testing and Counseling in a National Commercially Insured Population

(2015) Joanne Armstrong et al.   JAMA Oncology

Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer

(2014) Lori A Sturtz et al.   BMC CANCER

Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation

(2014) Amy P.M. Finch et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

Variants of uncertain significance inBRCAtesting: evaluation of surgical decisions, risk perception, and cancer distress

(2013) JO Culver et al.   CLINICAL GENETICS

BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

(2012) Kathryn Alsop et al.   JOURNAL OF CLINICAL ONCOLOGY

Triple-negative breast cancer in Hispanic patients

(2011) Fernando Lara-Medina et al.   CANCER

BRCA1andBRCA2mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer

(2009) Michael J. Hall et al.   CANCER

Variation in breast cancer subtypes with age and race/ethnicity

(2009) Carol A. Parise et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications

(2009) Allison W Kurian   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

What women with ovarian cancer think and know about genetic testing

(2008) Robin A. Lacour et al.   GYNECOLOGIC ONCOLOGY